Stock screener

XERS

Conviction 88HealthcareScan · Mon, Aug 10, 2026
XERS$7.99+0.76%
ResistanceSupportVol 14Insider sell
63 bars
3
Vol MA14 1.98M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Xeris Biopharma Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.xerispharma.com ↗
Price7.99
Change+0.76%
Gap-0.76%
Rel volume3.14×
Avg volume1.8M
Avg $ vol14.79M
SMA 208.30
SMA 507.66
SMA 2007.05
Price vs 50+4.34%
Price vs 200+13.33%
MA stackbullish
50/200 cross—
Supertrenddown · 8.38
RSI (14)49
MACD hist-0.12
MACD cross—
Stoch %K / %D55 / 40
ADX (14)27
+DI / −DI26 / 31
RSI divergence—
MACD divergence—
ATR %+4.67%
ADR %3.93%
52w high9.90
52w low5.29
From 52w high-19.29%
Above 52w low+51.04%
New 52w highNo
SqueezeOff
Bollinger width15.90%
%B0.27
Donchian pos48.21%
Donchian high9.00
Donchian low7.05
AVWAP (52w high)7.03
vs AVWAP high+13.73%
AVWAP (52w low)7.00
vs AVWAP low+14.12%
OBV trendUp
Chaikin MF (20)0.17
Today vs 20d3.14×
Avg vol (14d)1.98M
Avg vol (20d)1.8M
Avg $ vol (20d)14.79M
Market cap1.46B
RS 3m (vs SPY)+13.91%
RS 6m (vs SPY)+0.65%
RS line new highNo
Trend template5/8
Technical rank63.6
1 week-1.72%
1 month-4.20%
3 months+22.36%
6 months+13.98%
1 year+21.06%
YTD+8.71%
P/E2629.49
P/B-149.65
P/S4.99
P/FCF52.89
EPS0.0000
Div yield—
ROE-5.69%
ROA0.13%
Debt/Eq-25.95
Current1.45
EV/EBITDA60.57
Gross margin—
Net margin0.19%
Rev growth43.72%
EPS growth101.01%
Price target11.40
Target upside42.68%
Analyst ratingBuy
Institutional65.92%
Ent. value1.59B
Revenue92.1M
Net income-31.1M
Gross profit7.84M
Free cash flow27.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out172.64M
Employees435
ListedThu, Jun 21, 2018
Free float153.98M
Float %92.8%
Short interest10.08M
Days to cover4.4d
Short volume43.6%
Squeeze score52 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.00 vs $0.02
Last surprise-100.0% miss
Setup gradeA+
Conviction88 / 100
Pattern quality—
Tech rank63.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance9.01
Support6.96
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Breaking out now
    Jun 9
    1 scan
  2. Setting up
    Jul 17
    1 scan

Congress activity

Disclosed STOCK Act trades in XERS

All disclosures →
No recent disclosed trades by Congress in XERS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XERS · 6 buys · 3 sells

InsiderSideShares
Pieper Steven
See Remarks · Common Stock · 2026-07-07
Sell27.6K
Pieper Steven
See Remarks · Common Stock · 2026-07-06
Sell17.4K
HALKUFF DAWN
Director · Common Stock · 2026-06-04
Grant24.19K
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director · Stock Option (Right to Buy) · 2026-06-04
Grant33K
HALKUFF DAWN
Director · Common Stock · 2026-06-04
Other—
Kong Garheng
Director · Common Stock · 2026-06-04
Grant24.19K
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director · Common Stock · 2026-06-04
Sell16K
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director · Common Stock · 2026-06-04
Grant24.19K
JOHNSON JOHN
Director · Common Stock · 2026-06-04
Grant24.19K
PERSKY MARLA
Director · Common Stock · 2026-06-04
Grant24.19K

SEC filings

EDGAR filings in XERS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.